Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

JACC: Basic to Translational Science, 2022
Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients

Kaye D., Nanayakkara S., Wang B. et al.

Olink Target 96CVDPathophysiologyPlasma

Neurotherapeutics, 2022
Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke

Simats A., Ramiro L., Valls R. et al.

Olink Target 96 MouseCVDNeurologyPathophysiologyTissue Lysate

Endocrine Connections, 2022
100 YEARS OF VITAMIN D: Combined hormonal contraceptives and vitamin D metabolism in adolescent girls

Öberg J., Jorde R., Figenschau Y. et al.

Olink Target 96EndocrinologyPathophysiologySerum

Frontiers in Cardiovascular Medicine, 2022
Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice

Kumawat A., Zegeye M., Paramel G. et al.

Olink Target 96 MouseCVDPathophysiologyPlasma

European Journal of Heart Failure, 2022
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

Ferreira J., Verdonschot J., Girerd N. et al.

Olink Target 96CVDPatient StratificationPlasma

Atherosclerosis, 2022
Impact of smoking on cardiovascular risk and premature ageing: Findings from the STANISLAS cohort

Rastogi T., Girerd N., Lamiral Z. et al.

Olink Target 96Wider Proteomics StudiesCVDPathophysiologyPlasma

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022
CSF proteomic signature predicts progression to Alzheimer's disease dementia

Vromen E., del Campo Milán M., Scheltens P. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationCSF

International Journal of Molecular Sciences, 2022
COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19

Costanzo M., Caterino M., Fedele R. et al.

Infectious DiseasesReview/editorial

British Journal of Dermatology, 2022
Interleukin‐17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Navrazhina K., Frew J., Grand D. et al.

Olink Target 96Dermatological DiseasesPatient StratificationSerum

Brain, 2022
Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity

Ruck T., Barman S., Schulte-Mecklenbeck A. et al.

Olink Explore 3072/384NeurologyPathophysiologySerumCSF

Inflammation, 2022
MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients

Gorreja F., Caër C., Rush S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Scientific Reports, 2022
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)

Klimczak-Tomaniak D., de Bakker M., Bouwens E. et al.

Olink Target 96CVDPatient StratificationPlasma

Nature Communications, 2022
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Al-Nesf M., Abdesselem H., Bensmail I. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

Life, 2022
Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy

Johansson M., Ulfenborg B., Andersson C. et al.

Olink Target 96CVDPathophysiologyCell Culture Supernatant

Molecular Cancer, 2022
Proteomics technologies for cancer liquid biopsies

Ding Z., Wang N., Ji N. et al.

OncologyReview/editorial

Journal of Clinical Medicine, 2022
Proteomics-Based Serum Alterations of the Human Protein Expression after Out-of-Hospital Cardiac Arrest: Pilot Study for Prognostication of Survivors vs. Non-Survivors at Day 1 after Return of Spontaneous Circulation (ROSC)

Hinkelbein J., Kolaparambil Varghese Johnson L., Kiselev N. et al.

Olink Target 96CVDPatient StratificationSerum

Journal of Thrombosis and Haemostasis, 2022
Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach

Rademaker E., Doorduijn D., Kusadasi N. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

PLOS ONE, 2022
Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus–A randomized, placebo-controlled cross-over study

Suhrs H., Nilsson M., Bové K. et al.

Olink Target 96Metabolic DiseasesCVDPatient StratificationBlood

Translational Psychiatry, 2022
A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder

Göteson A., Isgren A., Sparding T. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationSerum

Scientific Reports, 2022
The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli

Lindblad A., Johansson C., Persson K. et al.

Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant

3195 publications